chr20-38918225-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015568.4(PPP1R16B):āc.1263C>Gā(p.Asp421Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015568.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP1R16B | NM_015568.4 | c.1263C>G | p.Asp421Glu | missense_variant | 11/11 | ENST00000299824.6 | |
PPP1R16B | NM_001172735.3 | c.1137C>G | p.Asp379Glu | missense_variant | 10/10 | ||
PPP1R16B | XM_011528768.4 | c.1275C>G | p.Asp425Glu | missense_variant | 10/10 | ||
PPP1R16B | XM_047440086.1 | c.666C>G | p.Asp222Glu | missense_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP1R16B | ENST00000299824.6 | c.1263C>G | p.Asp421Glu | missense_variant | 11/11 | 1 | NM_015568.4 | P1 | |
PPP1R16B | ENST00000373331.2 | c.1137C>G | p.Asp379Glu | missense_variant | 10/10 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727242
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.1263C>G (p.D421E) alteration is located in exon 11 (coding exon 10) of the PPP1R16B gene. This alteration results from a C to G substitution at nucleotide position 1263, causing the aspartic acid (D) at amino acid position 421 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.